Best Poster (#B7-0332): “Inhibition of the PI3K-AKT signalling pathway to overcome therapy resistance in melanoma-derived brain metastasis” by H Niessner et al [4], University Hospital Tübingen. Here, AKT1 is linked to melanoma.